Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa01:22

Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa

The pH of urine, the drug's pKa, and the urine flow rate are vital parameters for drug reabsorption and excretion. Urinary pH varies between 4.6 and 8.0 and is influenced by diet, drug intake, and the patient's pathophysiology. It affects a drug's ionization state and reabsorption. For instance, carbohydrate-rich food produces alkaline urine promoting drug excretion, while proteins and certain medications like ascorbic acid lead to acidic urine enhancing reabsorption.
The pKa of a drug,...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Renal Regulation of Acid-Base Balance01:29

Renal Regulation of Acid-Base Balance

Metabolic reactions in the body produce nonvolatile acids, such as sulfuric acid, which generate an acid load of approximately 1 mEq of H+ per kilogram of body weight daily. Excreting H+ in the urine is essential to balance this acid load.
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
Renal Drug Excretion: Overview01:15

Renal Drug Excretion: Overview

As primary excretory organs, the kidneys maintain homeostasis by removing waste substances from the bloodstream. They comprise over a million units called nephrons, which serve as the kidney's functional units.
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules out...
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multimodal Diagnostic Imaging of Metabolic Dysfunction-Associated Steatotic Liver Disease: Noninvasive Analyses by Photoacoustic Ultrasound and Magnetic Resonance Imaging.

The American journal of pathology·2025
Same author

Editorial: Insights in renal and epithelial physiology: 2023.

Frontiers in physiology·2024
Same author

Reverse epidemiology of obesity paradox: Fact or fiction?

Physiological reports·2024
Same author

SGLT2 inhibition leads to a restoration of hepatic and circulating metabolites involved in the folate cycle and pyrimidine biosynthesis.

American journal of physiology. Gastrointestinal and liver physiology·2024
Same author

Nascent shifts in renal cellular metabolism, structure, and function due to chronic empagliflozin in prediabetic mice.

American journal of physiology. Cell physiology·2024
Same author

Sex Modulates Response to Renal-Tubule-Targeted Insulin Receptor Deletion in Mice.

International journal of molecular sciences·2023
Same journal

Blood Pressure Responses to Dietary Salt in Renin-Deficient Dahl Salt-Sensitive Rats.

American journal of physiology. Renal physiology·2026
Same journal

Cytokine Profiles in Patients with Chronic Kidney Disease and Low Sexual Function.

American journal of physiology. Renal physiology·2026
Same journal

Renovascular disease induces functionally relevant, locus-specific alterations to DNA methylation and hydroxymethylation in swine scattered tubular-like cells.

American journal of physiology. Renal physiology·2026
Same journal

Nitrite Protects Against Cardiac Surgery-Associated Acute Kidney Injury via Inflammation Suppression: Insights from a Rat Cardiopulmonary Bypass Model.

American journal of physiology. Renal physiology·2026
Same journal

Etanercept attenuates TNFα-mediated kidney injury in a rat model of brain death kidney donation.

American journal of physiology. Renal physiology·2026
Same journal

Phosphorylation of aquaporin-2 at serine 269 in urinary extracellular vesicles reflects renal vasopressin activity in rats.

American journal of physiology. Renal physiology·2026
See all related articles

Related Experiment Video

Updated: May 14, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Lithium: a versatile tool for understanding renal physiology.

Bellamkonda K Kishore1, Carolyn M Ecelbarger

  • 1Nephrology Research (151M) VA SLC Health Care System, 500 Foothill Dr, Salt Lake City, UT 84148, USA. BK.Kishore@hsc.utah.edu

American Journal of Physiology. Renal Physiology
|February 15, 2013
PubMed
Summary
This summary is machine-generated.

Lithium is a valuable research tool in kidney studies, revealing new insights into vasopressin and aldosterone systems. Its effects challenge existing concepts in renal physiology and pathophysiology, opening new research avenues.

Keywords:
aldosteronearginine vasopressindiabetes insipidusglycogen synthase kinase-3prostaglandinspurinergic signaling

Related Experiment Videos

Last Updated: May 14, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Area of Science:

  • Renal Physiology
  • Molecular Biology
  • Pathophysiology

Background:

  • Lithium's unique interactions with kidney cells make it a crucial research tool.
  • Its effects are intricately linked to vasopressin and aldosterone systems and regulated membrane channels.

Purpose of the Study:

  • To review the state-of-the-art knowledge on lithium's role in understanding kidney molecular physiology.
  • To provide a comprehensive view of how lithium challenges established concepts in renal physiology and pathophysiology.
  • To highlight future research directions for lithium in the renal community.

Main Methods:

  • Review of existing literature on lithium's effects on renal physiology.
  • Analysis of studies investigating lithium's impact on cellular signaling pathways.
  • Examination of proteomic and metabolomic profiling in lithium-treated rats.

Main Results:

  • Lithium challenges established roles of adenylyl cyclase and prostaglandins in aquaporin-2 gene transcription.
  • Purinergic signaling's role in lithium-induced polyuria has been elucidated.
  • The epithelial sodium channel (ENaC) is highlighted as critical in lithium-induced nephrogenic diabetes insipidus (NDI).
  • Lithium's inhibition of glycogen synthase kinase-3β (GSK3β) opens new research avenues for urinary concentration and renal development.
  • Proteomic and metabolomic studies offer insights into kidney metabolic adaptation and the multifactorial nature of acquired NDI.

Conclusions:

  • Lithium serves as a versatile tool for advancing molecular renal physiology.
  • Lithium's effects necessitate a re-evaluation of long-standing concepts in renal physiology and pathophysiology.
  • Further research utilizing lithium promises to yield paradigm shifts in understanding kidney function and disease.